These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 176784)

  • 21. Poliovirus-binding inhibition ELISA for evaluation of immune response to oral poliovirus vaccine: a possible alternative to the neutralization test.
    Ivanov AP; Dragunsky EM; Ivanova OE; Rezapkin GV; Potapova SG; Chumakov KM
    Hum Vaccin; 2005; 1(3):102-5. PubMed ID: 17012865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunochemical studies of polioviruses: identification of immunoreactive virus capsid polypeptides.
    Thorpe R; Minor PD; Mackay A; Schild GC; Spitz M
    J Gen Virol; 1982 Dec; 63(2):487-92. PubMed ID: 6185628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hit-and-run neutralization of poliovirus.
    Brioen P; Rombaut B; Boeyé A
    J Gen Virol; 1985 Nov; 66 ( Pt 11)():2495-9. PubMed ID: 2997379
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neutralization of diphtheria toxin by human immunoglobulin classes and subunits.
    Ourth DD
    Immunochemistry; 1974 May; 11(5):223-5. PubMed ID: 4414805
    [No Abstract]   [Full Text] [Related]  

  • 25. Neutralization of poliovirus by a monoclonal antibody: kinetics and stoichiometry.
    Icenogle J; Shiwen H; Duke G; Gilbert S; Rueckert R; Anderegg J
    Virology; 1983 Jun; 127(2):412-25. PubMed ID: 6306918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The mechanism of bacteriophage T4 neutralization: effects of univalent antibody fragments on T4 adsorption kinetics.
    Stemke GW; Knight WS; Butz E; Gates DJ
    Can J Microbiol; 1974 Apr; 20(4):499-508. PubMed ID: 4597643
    [No Abstract]   [Full Text] [Related]  

  • 27. [Antigenicity determination of inactivated poliovirus--the micro-neutralization inhibition test].
    Jiang SD; Pye D
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1985 Aug; 7(4):309-12. PubMed ID: 3011295
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparison of the immune response of the rabbit to virulent and attenuated strains of type 1 poliovirus.
    Gaudin OG; Viac J; Thouvenot D; Sohier R
    Bull World Health Organ; 1974; 50(6):479-5. PubMed ID: 4376464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An analysis of the physical and chemical factors involved in the reactivation of neutralized poliovirus by the method of freezing and thawing.
    Mandel B
    Virology; 1973 Feb; 51(2):358-69. PubMed ID: 4348304
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparative efficiency of detection of anti-polio IgM and IgG antibody in neutralization, complement fixation and agar gel diffusion precipitation reactions.
    Mirzayants GK; Pervikov YV; Gubenko TL; Voroshilova MK
    Acta Virol; 1976 Jun; 20(3):266. PubMed ID: 9811
    [No Abstract]   [Full Text] [Related]  

  • 31. Analysis of specificity of antibodies contained in antiserum against poliovirus with mutants resistant to inhibitors in equine serum.
    Urasawa S; Urasawa T; Kanamitsu M
    J Immunol; 1974 Aug; 113(2):537-42. PubMed ID: 4367633
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunological reactivity of antisera to sodium dodecyl sulfate-derived polypeptides of polyoma virions.
    McMillen J; Consigli RA
    J Virol; 1977 Mar; 21(3):1113-20. PubMed ID: 191638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Homology of surface receptors for poliovirus on mammalian cell lines.
    Much DH; Zajac I
    J Gen Virol; 1973 Nov; 21(2):385-90. PubMed ID: 4357750
    [No Abstract]   [Full Text] [Related]  

  • 34. Monospecific antisera against capsid polypeptides of poliovirus type 1 distinguish antigenic structures of poliovirus proteins.
    Wiegers KJ; Dernick R
    J Gen Virol; 1983 Apr; 64 (Pt 4)():777-85. PubMed ID: 6300300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of monoclonal antibodies for the identification of the antigenic site for poliovirus neutralization.
    Minor PD; Schild GC; Evans D; Ferguson M; Almond J
    Dev Biol Stand; 1984; 57():171-5. PubMed ID: 6084608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytotoxicity by antigen aggregation. Adenovirus neutralization assays as a model.
    Kjellén L
    Arch Gesamte Virusforsch; 1972; 39(1):1-12. PubMed ID: 4117915
    [No Abstract]   [Full Text] [Related]  

  • 37. Principal and subsidiary antigenic sites of VP1 involved in the neutralization of poliovirus type 3.
    Minor PD; Evans DM; Ferguson M; Schild GC; Westrop G; Almond JW
    J Gen Virol; 1985 May; 66 ( Pt 5)():1159-65. PubMed ID: 2582084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Revertants of poliovirus escape mutants: new insights into antigenic structures.
    Ketterlinus R; Wiegers K; Dernick R
    Virology; 1993 Feb; 192(2):525-33. PubMed ID: 8380664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of a monoclonal antibody and of DNA recombinant technology for the localization of a poliovirus neutralization epitope in viral capsid polypeptide VP1.
    Bruneau P; van der Werf S; Wychowski C; Siffert O; Girard M
    Dev Biol Stand; 1984; 57():177-85. PubMed ID: 6084609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The interaction of neutralized poliovirus with HeLa cells. I. Adsorption.
    Mandel B
    Virology; 1967 Feb; 31(2):238-47. PubMed ID: 4289999
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.